{"id":124,"date":"2013-03-26T08:46:26","date_gmt":"2013-03-26T08:46:26","guid":{"rendered":"http:\/\/www.farmacovigilanciacanarias.org\/noticias\/?p=124"},"modified":"2013-03-26T08:46:26","modified_gmt":"2013-03-26T08:46:26","slug":"nota-informativa-muh-fv-082013","status":"publish","type":"post","link":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/2013\/03\/26\/nota-informativa-muh-fv-082013\/","title":{"rendered":"Nota Informativa MUH (FV), 08\/2013"},"content":{"rendered":"<p><a href=\"http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/2013\/NI-MUH_FV_08-2013-cilostazol.htm\">Cilostazol (<img decoding=\"async\" alt=\"Tri\u00e1ngulo amarillo\" src=\"http:\/\/www.aemps.gob.es\/diseno\/img\/triangulo.gif\" \/>Ekistol\u00ae,\u00a0<img decoding=\"async\" alt=\"Tri\u00e1ngulo amarillo\" src=\"http:\/\/www.aemps.gob.es\/diseno\/img\/triangulo.gif\" \/>Pletal\u00ae): finalizaci\u00f3n de la revaluaci\u00f3n de la relaci\u00f3n beneficio-riesgo y restricciones de uso<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cilostazol (Ekistol\u00ae,\u00a0Pletal\u00ae): finalizaci\u00f3n de la revaluaci\u00f3n de la relaci\u00f3n beneficio-riesgo y restricciones de uso<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,4],"tags":[],"class_list":["post-124","post","type-post","status-publish","format-standard","hentry","category-alertas","category-seguridad"],"_links":{"self":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/comments?post=124"}],"version-history":[{"count":2,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/124\/revisions"}],"predecessor-version":[{"id":126,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/124\/revisions\/126"}],"wp:attachment":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/media?parent=124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/categories?post=124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/tags?post=124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}